Researcher
Eveline Torfs
- Keywords:Pharmacy and pharmacology
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal chemistry, Medicinal products, Pharmaceutical analysis and quality assurance, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences, Other medical and health sciences
Affiliations
- Laboratory for Microbiology, Parasitology and Hygiene (LMPH) (Research group)
Member
From1 Jan 2016 → 5 Jan 2020
Projects
1 - 1 of 1
- Biological evaluation of 1,3-diaryltriazenes and their mechanism of action on Mycobacterium tuberculosis.From1 Feb 2016 → 5 Jan 2020Funding: FWO Strategic Basic Research Grant
Publications
1 - 10 of 10
- Novel thiazolidinedione-hydroxamates as inhibitors of Mycobacterium tuberculosis virulence factor Zmp1(2020)
Authors: Veronika Slachtova, Marek Sebela, Eveline Torfs, Lauren Oorts, Davie Cappoen, Karel Berka, Vaclav Bazgier, Lucie Brulikova
- The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis(2019)
Authors: Davie Cappoen, Eveline Torfs, Tamara Meiresonne, Pieter Claes, Elena Semina, Francis Holvoet, Maira Bidart de Macedo, Freya Cools, An Matheeussen, Kevin Van Calster, et al.
- Optimization and characterization of a Galleria mellonella larval infection model for virulence studies and the evaluation of therapeutics against Streptococcus pneumoniae(2019)
Authors: Freya Cools, Eveline Torfs, Juliana Aizawa Porto de Abreu, Bieke Vanhoutte, Louis Maes, Guy Caljon, Peter Delputte, Davie Cappoen, Paul F R C M Cos
- Opportunities for overcoming mycobacterium tuberculosis drug resistance(2019)
Authors: Eveline Torfs, Paul F R C M Cos, Davie Cappoen
- In vitro biological investigation of novel anti-tubercular compound classes and the development of improved research tools(2019)
Authors: Eveline Torfs, Paul F R C M Cos, Louis Maes, Davie Cappoen
Number of pages: 286 - Synthesis and antitubercular activity of 1-and 3-substituted benzo[g]isoquinoline-5,10-diones(2019)
Authors: Robert Smets, Eveline Torfs, Filip Lemière, Paul F R C M Cos, Davie Cappoen, Kourosch Abbaspour Tehrani
Pages: 2923 - 2939 - Streptococcus pneumoniae galU gene mutation has a direct effect on biofilm growth, adherence and phagocytosis in vitro and pathogenicity in vivo(2018)
Authors: Freya Cools, Eveline Torfs, Bieke Vanhoutte, Maira Bidart de Macedo, L. Bonofiglio, M. Mollerach, Louis Maes, Guy Caljon, Peter Delputte, Davie Cappoen, et al.
- Synthesis and in vitro investigation of halogenated 1,3-bis(4-nitrophenyl)triazenide salts as antitubercular compounds(2018)
Authors: Eveline Torfs, Jure Vajs, Maira Bidart de Macedo, Freya Cools, Bieke Vanhoutte, Yury Gorbanev, Annemie Bogaerts, Luc Verschaeve, Guy Caljon, Louis Maes, et al.
Pages: 631 - 640 - Design, synthesis and antitubercular potency of 4-hydroxyquinolin-2(1H)-ones(2017)
Authors: Maira Bidart de Macedo, Roman Kimmel, Damijana Urankar, Martin Gazvoda, Antonio Peixoto, Freya Cools, Eveline Torfs, Luc Verschaeve, Emerson Silva Lima, Antonin Lycka, et al.
Pages: 491 - 500 - Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia(2017)
Authors: Bieke Vanhoutte, Davie Cappoen, Maira Bidart de Macedo, Freya Cools, Eveline Torfs, Tom Coenye, Wim Martinet, Guy Caljon, Louis Maes, Peter Delputte, et al.
Pages: 181 - 188